Overview
Below is a consolidated review of the most significant insider transactions disclosed for Friday, January 24, 2026. The activity includes both significant insider purchases that boosted direct ownership stakes and large disposals by senior executives carried out under pre-arranged plans or through concurrent option exercises. Transactions reported here include specific share counts, prices, dates and any associated derivative instruments such as warrants or options where disclosed.
Top Buys
Several company insiders and large shareholders increased their holdings in recent trades.
-
QT Imaging Holdings, Inc. (NASDAQ: QTIH) - Avi Katz, the company chairman, executed a material purchase on January 22, 2026. Katz acquired 24,107 shares at $6.43 per share, for a total cash outlay of $155,008. That purchase raised his direct shareholdings to 413,452 shares. In addition to the common stock purchase, Katz obtained 48,214 private warrants exercisable into common shares at an exercise price of $6.43, with an expiration date of July 22, 2036.
-
BERKLEY W R CORP (NYSE: WRB) - Mitsui Sumitomo Insurance Co., LTD., identified as a ten-percent owner, expanded its position via three transactions between January 22 and January 23, 2026, totaling about $46.9 million. The purchases comprised 330,000 shares at a weighted average price of $67.4505 on January 22; followed by 201,081 shares at $66.7699 and 166,919 shares at $67.1803 on January 23.
-
RLI Corp (NYSE: RLI) - Chief Executive Officer Craig W. Kliethermes bought 5,000 shares on January 23, 2026. The purchase occurred at $57.45 per share and was valued at $287,250. After that transaction, Kliethermes directly owns 143,990 shares of RLI Corp.
-
Consumers Bancorp Inc (NASDAQ: CBKM) - Director David R. Bickerton purchased a total of 200 shares on January 23, 2026, in two related transactions. One block of 100 shares was purchased directly and another 100 shares were bought indirectly through a spouse. The trades occurred at prices between $27.33 and $27.3988 per share, costing $5,472 in aggregate. Post-transaction, Bickerton directly owns 4,306 shares. The company’s market capitalization was reported as $84.59 million, with a price-to-earnings ratio of 8.8 and a dividend yield of 3.12 percent; it has maintained dividend payments for 27 consecutive years.
-
Iridex Corp (NASDAQ: IRIX) - Chief Financial Officer Romeo R. Dizon purchased 5,221 shares on January 23, 2026, at a weighted average price of $1.4779 per share, with per-share prices ranging from $1.475 to $1.48. The transaction totaled $7,716. Following that purchase, Dizon owns 105,661 shares directly. The stock’s recent price movement included a one-week return of 5.67 percent and a year-to-date gain of 30.7 percent.
Top Sells
Several high-profile sales by executives and senior managers were also disclosed, including planned dispositions and simultaneous option exercises.
-
Royalty Pharma plc (NASDAQ: RPRX) - Terrance P. Coyne, Executive Vice President and Chief Financial Officer, sold 69,582 Class A Ordinary Shares on January 20, 2026. The sales netted roughly $2.7 million, executed at a weighted average price of $39.3484 per share, with individual sale prices ranging from $38.86 to $39.66. The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on August 8, 2025.
-
Axsome Therapeutics (NASDAQ: AXSM) - Chief Financial Officer Nick Pizzie sold 12,000 shares on January 22, 2026, for proceeds of $2,255,040 at a weighted average price of $187.92 per share, with individual sale prices between $185.09 and $191.12. On that same date, Pizzie exercised stock options to acquire an additional 12,000 shares at an exercise price of $3.50 per share, for $42,000 in option exercises. The options are noted to expire in 2028.
-
Alphabet Inc. (NASDAQ: GOOGL) - Chief Executive Officer Pichai Sundar sold 30,521 shares of Class C Capital Stock on January 21, 2026. Those sales generated $10,637,367, with execution prices spanning $320.35 to $331.97 per share. After the sale, Sundar’s direct ownership of Class C Capital Stock stood at 2,211,872 shares, and he still directly owns 227,560 shares of Class A Common Stock.
-
BlackRock, Inc. (NYSE: BLK) - Senior Managing Director Kushel J. Richard sold 20,000 shares on January 21, 2026, at $1,125.00 per share, totaling $22,500,000. On the same day Richard exercised options to acquire 20,000 shares at $513.50 per share, which amounted to $10,270,000. BlackRock’s reported valuation metrics included a P/E ratio of 31.5, a market capitalization of $183.67 billion, and a dividend yield of 2.03 percent.
-
DoorDash, Inc. (NASDAQ: DASH) - President and Chief Operating Officer Prabir Adarkar sold 11,490 shares of Class A Common Stock on January 20, 2026, for approximately $3,068,869, with execution prices between $200.732 and $207.41 per share. That same day Adarkar exercised stock options to acquire 15,000 shares at $7.16 per share, for $107,400.
Why track insider transactions
Insider trades can provide investors with an additional lens into how insiders are positioning around their companies. Purchases by executives, board members or significant shareholders may be interpreted as a sign of confidence in a company's prospects, while sales can reflect other considerations. It is important to remember, however, that insiders sell for varied reasons including portfolio rebalancing, tax planning or personal liquidity needs. Some sales are conducted under pre-established trading plans, such as the 10b5-1 plan noted for the Royalty Pharma transaction, which can separate the timing of the sale from contemporaneous informational advantages.
Insider activity should be one component of a broader investment assessment that also considers financial results, market dynamics and industry conditions. The transactions reported here span healthcare, insurance, regional banking, biotechnology, asset management and consumer technology, underscoring that insider activity affects multiple sectors and that interpretation of any single trade should be contextualized within company-specific and market-wide factors.
Concluding note
The filings summarized above reflect the formal disclosure of insider trades reported for the period ending January 24, 2026. Each listed transaction includes the share counts, prices and any related derivative instruments disclosed in regulatory filings. Investors seeking to use insider filings as an input to decision-making should corroborate these reported items with broader financial analysis and an understanding of the individual circumstances that can drive insider buying or selling.